BiotechTube
Home/Editas Medicine/Linda C. Burkly
LC

Linda C. Burkly

Executive Vice President and Chief Scientific Officer

Editas Medicine

Therapeutic Areas

CardiovascularHematologyOncology

Editas Medicine Pipeline

DrugIndicationPhase
EDIT-401Hyperlipidemia & Atherosclerotic Cardiovascular Disease (ASCVD)Preclinical
Undisclosed In Vivo ProgramSickle Cell Disease (SCD) / Beta thalassemiaResearch
Collaborative Alpha-Beta T-cell AssetsOncologyVarious (Partner-led)
Collaborative Gamma-Delta T-cell AssetsOncologyVarious (Partner-led)

Leadership Team at Editas Medicine

GO
Gilmore O’Neill
President and Chief Executive Officer
BB
Brieana Buckley
Senior Vice President, Development and Program Leadership
DG
Damien Grierson
Senior Vice President and General Counsel
FP
Frank Panaccio
Senior Vice President and Chief Business Officer
AP
Amy Parison
Senior Vice President and Chief Financial Officer
GW
Gregory Whitehead
Executive Vice President and Chief Technical and Quality Officer
View full Editas Medicine profile